About the consolidation
The impetus for consolidating MSFHR and BC AHSN was synergy — which literally means the interaction or cooperation of two or more organizations (in this case) to produce a combined effect greater than the sum of their separate effects. This concept was captured into the new brand, a mosaic and kaleidoscope of colour that together are greater than the sum of its parts. The top right corner creates an upward pointing arrow that forms a distinct, identifiable mark while evoking the idea of forward motion and innovation.
As one organization — and embracing a dual role of “doing” and “influencing” — we are in a much stronger position to work with our partners and stakeholders to strengthen research capacity across the province, support evidence-informed decision making in health care, increase the competitiveness of our life sciences sector, and maximize the social and economic benefits of health research in BC.
As a provincial organization, our work extends across many Indigenous lands and territories throughout British Columbia. We acknowledge with respect and humility that our Vancouver offices are located on the traditional and unceded territories of the xʷməθkʷəy̓əm (Musqueam), Skwxwú7mesh (Squamish), and səl̓ilwətaɁɬ (Tsleil-Waututh) Nations.
Although we have a new name, all current funding programs historically offered by MSFHR are running as scheduled; the work of the BC SUPPORT Unit, Clinical Trials BC, and Research Ethics BC is moving forward as planned; and the organization continues to drive knowledge translation to improve the use of research evidence in practice and policy. Programs will continue to support equity, diversity, and inclusion, which is important to nurture inclusive excellence, which in turn drives discovery and helps build a more innovative and impactful health research system.
About this website
Over the next year, the existing websites of Michael Smith Foundation for Health Research and British Columbia Academic Health Science Network will be consolidated here under Michael Smith Health Research BC. As we work to merge our websites, you may notice that some of the links navigate to the individual websites. You can also use the list of quick links below to navigate directly to the information you need.
Board of Directors
Chair, Finance & Audit Committee
Chair, Governance Committee
Senior Leadership Team
Bev Holmes, PhD, C. Dir
President & CEO
Stirling Bryan, PhD, FCAHS
Chief Scientific Officer
Cecillia Colbeck, CPA, CGA
Chief Financial Officer
Terri Fleming, MBA
Unit Director, Research Ethics BC
Danielle Lavallee, PharmD, PhD
Acting VP Research
Alison Orth, BBA, CCRC
Unit Director, Clinical Trials BC
Zena Sharman, PhD
Executive Lead, Organizational Integration & Transformation
We’re here to help. Whether you have questions about our funding programs, patient-oriented research programs, clinical trials, or harmonized ethics review process, connect with us at:
1285 W Broadway #200
Vancouver, BC V6H 3X8
1367 W Broadway #420
Vancouver, BC V6H 4A7
About Michael Smith
Michael Smith Health Research BC is named in honour of BC’s first Nobel Laureate, Dr. Michael Smith. A pre-eminent chemist and molecular biologist, Dr. Smith was dedicated to building BC’s health research capacity and nurturing the next generation of research innovators. His distinguished career and longstanding commitment to supporting emerging scientific talent helped establish BC as a hub for world-class health research.